Akari Therapeutics (AKTX) Selling, General & Administrative (2014 - 2026)

Akari Therapeutics (AKTX) Selling, General & Administrative (2014 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	SG&A (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	17.02 Mn
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	1.32 Mn
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-37.00 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	2.17 Mn
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-1.52 Mn
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	217,225.00
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	493.70 Mn
9	Abivax	90.15 Bn	90.15 Bn	-	-7.36 Mn
10	Regeneron Pharmaceuticals	63.59 Bn	54.83 Bn	3.31 Bn	647.70 Mn

Download Data